Mukesh Misra, MD
Neurological Surgery · Lancaster, CANPI 1679580096
Payments from drug & device makers
Across 42 payments — averaging $47.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alphatec Spine, Inc$1K
- Lilly USA, LLC$108
- UCB, Inc.$92
- Amgen$88
- Biogen$78
- Genentech USA, Inc.$74
- plus $458 from 18 others
What the payments were for
- Travel & lodging$1,08054%
- Food & beverage$91246%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alphatec Spine, Inc | 2 | $1,094 |
| Lilly USA, LLC | 5 | $108 |
| UCB, Inc. | 3 | $92 |
| Amgen | 6 | $88 |
| Biogen | 3 | $78 |
| Genentech USA, Inc. | 3 | $74 |
| Livanova USA, Inc. | 2 | $37 |
| Acadia Pharmaceuticals Inc | 1 | $35 |
| Argenx US, Inc. | 1 | $35 |
| AbbVie | 2 | $34 |
| CSL Behring | 1 | $31 |
| Amneal Pharmaceuticals LLC | 1 | $29 |
| Octapharma USA, Inc. | 1 | $27 |
| Neurelis, Inc. | 1 | $27 |
| Catalyst Pharmaceuticals, Inc. | 1 | $27 |
| Merck | 1 | $25 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Novartis | 1 | $20 |
| Eisai Inc. | 1 | $20 |
| Medtronic | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Other - Miscellaneous$1,080
How this compares
$1,992 in reported general payments places this provider in the 40th percentile of 773 neurological surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 326 | $14,200 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 319 | $7,973 |
| Baclofen | 380 | $4,341 |
| Oxycodone Hcl | 124 | $2,885 |
| Gabapentin | 277 | $2,447 |
| Lidocaine | 28 | $2,288 |
| Morphine Sulfate ErMorphine Sulfate | 68 | $1,502 |
| Cyclobenzaprine Hcl | 77 | $1,425 |
| Carisoprodol | 89 | $1,359 |
| Pregabalin | 98 | $1,134 |
| Tramadol Hcl ErTramadol Hcl | 11 | $1,048 |
| Ibuprofen | 181 | $1,035 |
| Tizanidine Hcl | 109 | $665 |
| Tramadol Hcl | 85 | $500 |
| Amitriptyline Hcl | 65 | $361 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Lancaster
- Geoffrey ManleySan Francisco$24.9M
- Christopher AmesSan Francisco$7.1M
- Jamshid SalehRedding$4.1M
- Bruce McCormackSan Francisco$3.9M
- Andrew SchreiberSanta Ana$3.9M
- Larry KhooLos Angeles$3M
- Jennie TaylorSan Francisco$2.7M
- Joseph CiacciSan Diego$2.6M
- Nicholas ButowskiSan Francisco$2.4M
- Samy AbdouSan Diego$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.